NASDAQ: SDGRSchrodinger Inc Stock
$27.44-0.81 (-2.87%)
Updated Sep 26, 2023
SDGR Price
$27.44
Fair Value Price
$31.25
Market Cap
$1.97B
52 Week Low
$15.85
52 Week High
$59.24
P/E
29.83x
P/B
3.23x
P/S
18.46x
PEG
1.32x
Dividend Yield
N/A
Revenue
$193.79M
Earnings
$66.35M
Gross Margin
59.6%
Operating Margin
37.33%
Profit Margin
34.2%
Debt to Equity
0.38
Operating Cash Flow
-$105M
Beta
1
Next Earnings
Nov 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A
SDGR Overview
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SDGR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SDGR ($27.44) is undervalued by 12.19% relative to our estimate of its Fair Value price of $31.25 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SDGR ($27.44) is not significantly undervalued (12.19%) relative to our estimate of its Fair Value price of $31.25 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SDGR ($27.44) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SDGR due diligence checks available for Premium users.
Be the first to know about important SDGR news, forecast changes, insider trades & much more!
SDGR News
Valuation
SDGR fair value
Fair Value of SDGR stock based on Discounted Cash Flow (DCF)
Price
$27.44
Fair Value
$31.25
Undervalued by
12.19%
SDGR ($27.44) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SDGR ($27.44) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SDGR ($27.44) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SDGR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.83x
Industry
55.14x
Market
14.06x
SDGR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SDGR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SDGR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.23x
Industry
3.07x
SDGR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SDGR price to earnings growth (PEG)
For valuing profitable companies with growth potential
SDGR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
SDGR's financial health
Profit margin
Revenue
$35.2M
Net Income
$4.3M
Profit Margin
12.2%
SDGR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SDGR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$841.6M
Liabilities
$230.3M
Debt to equity
0.38
SDGR's short-term assets ($591.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SDGR's short-term assets ($591.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SDGR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$18.4M
Investing
$67.2M
Financing
$4.5M
SDGR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SDGR vs Health Information Service Stocks
Schrodinger Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.